You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 133 No. 11, November 1997 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  DEVELOPMENT OF MEASUREMENT TOOLS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Reliability Testing of the Dermatology Index of Disease Severity (DIDS)

An Index for Staging the Severity of Cutaneous Inflammatory Disease

Holly B. Faust, MD; René Gonin, PhD; Tsu-Yi Chuang, MD, MPH; Charles W. Lewis, MD; Catherine A. Melfi, PhD; Evan R. Farmer, MD

Arch Dermatol. 1997;133(11):1443-1448.


Abstract



Objectives
To describe a new severity of illness index for inflammatory skin disease called the Dermatology Index of Disease Severity (DIDS), and to show its preliminary use and reliability in staging disease in patients with psoriasis and dermatitis.

Design
Interobserver rating study using the DIDS with as many as 10 observers independently rating the same patient at a single point in time.

Setting
Ambulatory care clinics at an academic medical center with patients from various socioeconomic backgrounds.

Patients
Thirty-four patients with psoriasis and 15 patients with dermatitis were included in the study.

Main Outcome Measures
The severity of illness for each patient was rated as 1 of 5 stages: 0, no evidence of clinical disease; I, limited disease; II, mild disease; III, moderate disease; and IV, severe disease. The degree of interobserver concordance was measured by the Cohen {kappa} statistic.

Results
All 5 stages were represented in the study of patients with psoriasis. The overall {kappa} statistic was 0.76, which is defined as substantial interobserver concordance. The use of the instrument in dermatitis showed good consensus in staging, where the {kappa} statistic was 0.41.

Conclusion
We introduce an easy and efficient instrument for staging the severity of illness in inflammatory cutaneous diseases. The reliability of the DIDS is demonstrated in patients with psoriasis and in patients with dermatitis.

Arch Dermatol. 1997;133:1443-1448



Author Affiliations



From the Departments of Dermatology (Drs Faust, Gonin, Chuang, Lewis, and Farmer) and Medicine (Drs Faust, Gonin, and Melfi), Indiana University Medical Center, and The Roudebush Veterans Affairs Medical Center (Dr Chuang), Indianapolis, Ind.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical outcome measures for cutaneous lupus erythematosus
Albrecht and Werth
Lupus 2010;19:1137-1143.
ABSTRACT  

The Marriage of Guidelines of Care and Outcomes
Farmer
Arch Dermatol 1997;133:1389-1391.
ABSTRACT  

Is a Simple Generic Index of Dermatologic Disease Severity an Attainable Goal?
Williams
Arch Dermatol 1997;133:1451-1452.
ABSTRACT  

Quality of Care in Dermatology: The State of (Measuring) the Art
Chren
Arch Dermatol 1997;133:1349-1351.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.